TScan Therapeutics (TCRX) Current Deferred Tax Assets (2021)
TScan Therapeutics (TCRX) has disclosed Current Deferred Tax Assets for 1 consecutive years, with $2.5 million as the latest value for Q2 2021.
TScan Therapeutics (TCRX) has disclosed Current Deferred Tax Assets for 1 consecutive years, with $2.5 million as the latest value for Q2 2021.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month